Liquid risperidone in the treatment of psychotic agitation.
Tsai
Caroline
C
Puzantian
Talia
T
D000284:Administration, Oral; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D001682:Biological Availability; D002986:Clinical Trials as Topic; D006801:Humans; D019999:Pharmaceutical Solutions; D011595:Psychomotor Agitation / Q000188:drug therapy* / Q000209:etiology; D011618:Psychotic Disorders / Q000150:complications* / Q000188:drug therapy; D018967:Risperidone / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use
D014150:Antipsychotic Agents; D019999:Pharmaceutical Solutions; D018967:Risperidone